Sign In
Buy SGMT
Sagimet Biosciences Stock Insider Power
Based on the 100 latest insides trades, we have calculated the insider power to be positive at 1.97. In total, the insiders bought 6.37M and sold 1.19M SGMT shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.
Insider Power
|
1.97 |
| ● Buy | 6.37M shares |
| ● Sell | 1.19M shares |
|
80% Buy Activity
Weak Negative Correlation
|
|
Historical Insider Trades
| Date | Type | Person | Role | Amount |
|---|---|---|---|---|
|
Feb 06, 2025 Buy |
Chauche Thierry Chief Financial Officer |
17 000 Value: $80.1K |
||
|
Feb 06, 2025 Buy |
Martins Eduardo Bruno Chief Medical Officer |
138 000 Value: $650.0K |
||
|
Feb 06, 2025 Buy |
Martins Eduardo Bruno Chief Medical Officer |
34 000 Value: $160.1K |
||
|
Feb 06, 2025 Buy |
Happel David President & CEO |
116 000 Value: $546.4K |
||
|
Feb 06, 2025 Buy |
Happel David President & CEO |
472 000 Value: $2.22M |
||
|
Feb 06, 2025 Buy |
Rozek Elizabeth General Counsel And Cco |
34 000 Value: $160.1K |
||
|
Feb 06, 2025 Buy |
Rozek Elizabeth General Counsel And Cco |
138 000 Value: $650.0K |
||
|
Feb 06, 2025 Buy |
Chauche Thierry Chief Financial Officer |
69 000 Value: $325.0K |
||
|
Feb 06, 2025 Buy |
Chauche Thierry Chief Financial Officer |
17 000 Value: $80.1K |
||
|
Aug 01, 2024 Buy |
Jarrett Jennifer Director |
113 895 Value: $396.4K |
||
|
Aug 01, 2024 Buy |
Phillips Anne M. Director |
113 895 Value: $396.4K |
||
|
Aug 01, 2024 Buy |
Jarrett Jennifer |
0 Value: $0 |
||
|
Aug 01, 2024 Buy |
Phillips Anne M. |
0 Value: $0 |
||
|
Aug 01, 2024 Buy |
Jarrett Jennifer Director |
113 895 Value: $396.4K |
||
|
Aug 01, 2024 Buy |
Phillips Anne M. Director |
113 895 Value: $396.4K |
||
|
Aug 01, 2024 Buy |
Jarrett Jennifer |
0 Value: $0 |
||
|
Aug 01, 2024 Buy |
Phillips Anne M. |
0 Value: $0 |
||
|
Jul 23, 2024 Sell |
Kemble George Executive Chairman |
23 625 Value: $74.8K |
||
|
Jul 23, 2024 Sell |
Kemble George Executive Chairman |
23 625 Value: $74.8K |
||
|
Jul 19, 2024 Sell |
Martins Eduardo Bruno Chief Medical Officer |
8 357 Value: $25.9K |
||
|
Jul 19, 2024 Sell |
Rozek Elizabeth General Counsel And Cco |
10 914 Value: $33.8K |
||
|
Jul 19, 2024 Sell |
Kemble George Executive Chairman |
14 062 Value: $43.6K |
||
|
Jul 19, 2024 Sell |
Martins Eduardo Bruno Chief Medical Officer |
8 357 Value: $25.9K |
||
|
Jul 19, 2024 Sell |
Rozek Elizabeth General Counsel And Cco |
10 914 Value: $33.8K |
||
|
Jul 19, 2024 Sell |
Kemble George Executive Chairman |
14 062 Value: $43.6K |
About Insider Power
Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.
It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.
While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.
* October 6th, 2025 - Tested on 5562 stocks
